LobbyingMerck Sharp & Dohme lobbying by quarter
Merck Sharp & Dohme's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $240K. Its first report covers Q3 2025; the issues it reports most are Pharmacy and Miscellaneous Tariff Bills.
Merck Sharp & Dohme
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $240K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $80K | 1 |
| Q4 2025 | $80K | 1 |
| Q1 2026 | $80K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$40K · 1 reports
- Tariffs$40K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
No house or agency named.
Firms it paid
| Firm | ||
|---|---|---|
| Ballard Partners | $320K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALISON ANWAY | LA to Senator Pat Roberts 2006-2010 | Q3 2025 |
| HUNTER MORGEN | Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020) | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Ballard Partners | $80K |
| 04/16for Q1 | Ballard Partners | $80K |
| 01/14for Q4 2025 | Ballard Partners | $80K |
| 25/10/17for Q3 2025 | Ballard Partners | $80K |
| 25/10/16for Q3 2025 | Ballard Partners | $50K |
| 25/09/02for Q3 2025 | Ballard Partners | Under $5,000 |